Individualized dose of rituximab ( DrugBank: Rituximab )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	1

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04127747 (ClinicalTrials.gov)	August 18, 2020	14/10/2019	Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus ...	A Multicenter, Randomized Controlled Clinical Study About Efficacy and Safety of Standard Dose and I ...	Autoimmune Diseases	Drug: Standard dose of rituximab;Drug: Individualized dose of rituximab	Second Affiliated Hospital, School of Medicine, Zhejiang University	NULL	Recruiting	18 Years	65 Years	All	110	Phase 4	China

First Previous1Next Last